{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:58:40Z","timestamp":1783490320193,"version":"3.55.0"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":231,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMW","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Loop diuretics are widely used in heart failure (HF) for symptom relief. Guidelines advise treating patients with the lowest possible dose of loop diuretics to maintain euvolaemia, based on expert opinion only. However, data on the safety of this practice are scarce. This analysis aims to investigate the clinical course after changing loop diuretics in stable HF patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>A post-hoc analysis from the TIME-CHF study was conducted in 622 patients. Daily loop diuretic doses were meticulously recorded, resulting in 11\u2009035 dose evaluations assessed. The frequency of relevant events within 30\u2009days (hospitalization, death, dose change) following an up-titration, down-titration, or no change in diuretic therapy was calculated. Risk of hospitalization and deaths 30\u2009days after down-titration was estimated after adjusting for congestion level. At baseline the cohort consisted mostly of males (59%), with a mean age of 77\u2009years. Patients were highly symptomatic with 76% classified as New York Heart Association class III or IV. Within 30\u2009days after a down-titration, diuretic dose necessitated an increase in 30.4% of cases, compared with 20.7% following up-titration and 8.0% on a stable dose. Hospitalization and death were significantly more frequent following down-titration (3.4% and 2% within 30\u2009days, respectively) than with a stable dose (1% and 0.6%, p\u2009&amp;lt;\u20090.001). Similar hospitalization rates were observed after up-titration. The risk of hospitalization doubled and of death tripled after down-titration in patients with similar congestion levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>There is a significant risk that reduction in diuretic dose requires restart or increase of diuretics within a short period. Additionally, there may be a significant risk associated with diuretic dose reduction. Therefore, HF patients need to be closely monitored after down-titration of loop diuretic therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ejhf.3714","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T08:49:05Z","timestamp":1751446145000},"page":"1393-1399","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Exploring Safety of Down-Titrating Diuretics in Heart Failure Management"],"prefix":"10.1093","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-8804-8700","authenticated-orcid":false,"given":"Chrit B.G.","family":"Geraeds","sequence":"first","affiliation":[{"name":"Department of Cardiology, CARIM, Maastricht University Medical Centre , Maastricht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5916-8735","authenticated-orcid":false,"given":"Anke","family":"Bruninx","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology (MAASTRO), GROW Research Institute for Oncology and Reproduction, Maastricht University Medical Centre , Maastricht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0422-7996","authenticated-orcid":false,"given":"Andre L.A.J.","family":"Dekker","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology (MAASTRO), GROW Research Institute for Oncology and Reproduction, Maastricht University Medical Centre , Maastricht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3448-5531","authenticated-orcid":false,"given":"Arantxa","family":"Barandiar\u00e1n Aizpurua","sequence":"additional","affiliation":[{"name":"Department of Cardiology, CARIM, Maastricht University Medical Centre , Maastricht ,","place":["The Netherlands"]},{"name":"Cardiology, Maastricht University Medical Centre , Maastricht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9105-8088","authenticated-orcid":false,"given":"Inigo","family":"Bermejo","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology (MAASTRO), GROW Research Institute for Oncology and Reproduction, Maastricht University Medical Centre , Maastricht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4356-8566","authenticated-orcid":false,"given":"Hans-Peter","family":"Brunner-La Rocca","sequence":"additional","affiliation":[{"name":"Department of Cardiology, CARIM, Maastricht University Medical Centre , Maastricht ,","place":["The Netherlands"]},{"name":"Cardiology, Maastricht University Medical Centre , Maastricht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"key":"2026021721461321200_ejhf3714-bib-0001","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"2026021721461321200_ejhf3714-bib-0002","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1067\/mhl.2002.126048","article-title":"Telemanagement of heart failure: A diuretic treatment algorithm for advanced practice nurses","volume":"31","author":"Mueller","year":"2002","journal-title":"Heart Lung"},{"key":"2026021721461321200_ejhf3714-bib-0003","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1503\/cmaj.051620","article-title":"Management of acute decompensated heart failure","volume":"176","author":"Allen","year":"2007","journal-title":"CMAJ"},{"key":"2026021721461321200_ejhf3714-bib-0004","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1016\/j.jacc.2011.10.910","article-title":"Diuretics and ultrafiltration in acute decompensated heart failure","volume":"59","author":"Felker","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2026021721461321200_ejhf3714-bib-0005","doi-asserted-by":"crossref","first-page":"108","DOI":"10.15420\/cfr.2017:10:1","article-title":"Dilemmas in the dosing of heart failure drugs: Titrating diuretics in chronic heart failure","volume":"3","author":"Pham","year":"2017","journal-title":"Card Fail Rev"},{"key":"2026021721461321200_ejhf3714-bib-0006","doi-asserted-by":"crossref","first-page":"15","DOI":"10.21037\/amj.2020.03.03","article-title":"Global epidemiology and future trends of heart failure","volume":"5","author":"Lippi","year":"2020","journal-title":"AME Med J"},{"key":"2026021721461321200_ejhf3714-bib-0007","doi-asserted-by":"crossref","first-page":"S191","DOI":"10.37765\/ajmc.2021.88673","article-title":"Heart failure population health considerations","volume":"27","author":"Patel","year":"2021","journal-title":"Am J Manag Care"},{"key":"2026021721461321200_ejhf3714-bib-0008","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s40273-020-00952-0","article-title":"A systematic review of medical costs associated with heart failure in the USA (2014\u20132020)","volume":"38","author":"Urbich","year":"2020","journal-title":"Pharmacoeconomics"},{"key":"2026021721461321200_ejhf3714-bib-0009","doi-asserted-by":"crossref","first-page":"2L","DOI":"10.1016\/S0002-9149(97)00843-6","article-title":"Overview of the treatment of heart failure","volume":"80","author":"Cohn","year":"1997","journal-title":"Am J Cardiol"},{"key":"2026021721461321200_ejhf3714-bib-0010","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0140-6736(11)60101-3","article-title":"Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: A randomised controlled trial","volume":"377","author":"Abraham","year":"2011","journal-title":"Lancet"},{"key":"2026021721461321200_ejhf3714-bib-0011","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/S0140-6736(23)00923-6","article-title":"Remote haemodynamic monitoring of pulmonary artery pressures in patients with chronic heart failure (MONITOR-HF): A randomised clinical trial","volume":"401","author":"Brugts","year":"2023","journal-title":"Lancet"},{"key":"2026021721461321200_ejhf3714-bib-0012","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.ahj.2005.10.022","article-title":"Management of elderly patients with congestive heart failure \u2013 design of the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF)","volume":"151","author":"Brunner-La Rocca","year":"2006","journal-title":"Am Heart J"},{"key":"2026021721461321200_ejhf3714-bib-0013","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1001\/jama.2009.2","article-title":"BNP-guided vs symptom-guided heart failure therapy: The Trial of Intensified vs standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF) randomized trial","volume":"301","author":"Pfisterer","year":"2009","journal-title":"JAMA"},{"key":"2026021721461321200_ejhf3714-bib-0014","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1093\/eurjhf\/hft076","article-title":"N-terminal pro brain natriuretic peptide-guided management in patients with heart failure and preserved ejection fraction: Findings from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF)","volume":"15","author":"Maeder","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"2026021721461321200_ejhf3714-bib-0015","doi-asserted-by":"crossref","first-page":"e679","DOI":"10.1016\/j.amjmed.2019.04.010","article-title":"Prognostic significance of longitudinal clinical congestion pattern in chronic heart failure: Insights from TIME-CHF trial","volume":"132","author":"Simonavi\u010dius","year":"2019","journal-title":"Am J Med"},{"key":"2026021721461321200_ejhf3714-bib-0016","volume-title":"Causal Inference: What if","author":"Hernan","year":"2024","edition":"1st ed."},{"key":"2026021721461321200_ejhf3714-bib-0017","volume-title":"R: A Language and Environment for Statistical Computing. 4.2.1","author":"R Development Core Team","year":"2010"},{"key":"2026021721461321200_ejhf3714-bib-0018","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.jacc.2019.12.059","article-title":"Diuretic therapy for patients with heart failure: JACC state-of-the-art review","volume":"75","author":"Felker","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2026021721461321200_ejhf3714-bib-0019","doi-asserted-by":"crossref","first-page":"200","DOI":"10.18773\/austprescr.2022.069","article-title":"Diuretics in the management of chronic heart failure: When and how","volume":"45","author":"Magdy","year":"2022","journal-title":"Aust Prescr"},{"key":"2026021721461321200_ejhf3714-bib-0020","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.1093\/eurheartj\/ehz554","article-title":"Short-term diuretic withdrawal in stable outpatients with mild heart failure and no fluid retention receiving optimal therapy: A double-blind, multicentre, randomized trial","volume":"40","author":"Rohde","year":"2019","journal-title":"Eur Heart J"},{"key":"2026021721461321200_ejhf3714-bib-0021","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1161\/CIRCULATIONAHA.107.696906","article-title":"Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure","volume":"116","author":"Solomon","year":"2007","journal-title":"Circulation"},{"key":"2026021721461321200_ejhf3714-bib-0022","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ahj.2007.01.041","article-title":"Repeated hospitalizations predict mortality in the community population with heart failure","volume":"154","author":"Setoguchi","year":"2007","journal-title":"Am Heart J"},{"key":"2026021721461321200_ejhf3714-bib-0023","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/ehf2.12677","article-title":"Outpatient treatment of worsening heart failure with intravenous and subcutaneous diuretics: A systematic review of the literature","volume":"7","author":"Wierda","year":"2020","journal-title":"ESC Heart Fail"},{"key":"2026021721461321200_ejhf3714-bib-0024","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1002\/ejhf.1796","article-title":"Association between loop diuretic dose changes and outcomes in chronic heart failure: Observations from the ESC-EORP Heart Failure Long-Term Registry","volume":"22","author":"Kapelios","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2026021721461321200_ejhf3714-bib-0025","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1161\/CIRCHEARTFAILURE.108.821785","article-title":"Loop diuretics in acute decompensated heart failure: Necessary? Evil? A necessary evil?","volume":"2","author":"Felker","year":"2009","journal-title":"Circ Heart Fail"},{"key":"2026021721461321200_ejhf3714-bib-0026","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1002\/ejhf.2664","article-title":"Congestion in heart failure: A circulating biomarker-based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European Society of Cardiology","volume":"24","author":"N\u00fa\u00f1ez","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"2026021721461321200_ejhf3714-bib-0027","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1053\/j.ackd.2021.03.003","article-title":"Lung ultrasound: A \u201cbiomarker\u201d for fluid overload?","volume":"28","author":"Suarez","year":"2021","journal-title":"Adv Chronic Kidney Dis"},{"key":"2026021721461321200_ejhf3714-bib-0028","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1038\/s41598-023-30900-9","article-title":"ECG-guided non-invasive estimation of pulmonary congestion in patients with heart failure","volume":"13","author":"Raghu","year":"2023","journal-title":"Sci Rep"},{"key":"2026021721461321200_ejhf3714-bib-0029","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1053\/euhj.2001.2783","article-title":"Guidelines for the diagnosis and treatment of chronic heart failure","volume":"22","author":"Remme","year":"2001","journal-title":"Eur Heart J"},{"key":"2026021721461321200_ejhf3714-bib-0030","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/eurheartj\/ehi204","article-title":"Guidelines for the diagnosis and treatment of chronic heart failure: Executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology","volume":"26","author":"Swedberg","year":"2005","journal-title":"Eur Heart J"},{"key":"2026021721461321200_ejhf3714-bib-0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2021.101285","article-title":"The diuretic effects of SGLT2 inhibitors: A comprehensive review of their specificities and their role in renal protection","volume":"47","author":"Delanaye","year":"2021","journal-title":"Diabetes Metab"}],"container-title":["European Journal of Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/27\/8\/1393\/66813371\/eurjhf_27_8_1393.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/27\/8\/1393\/66813371\/eurjhf_27_8_1393.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T02:46:35Z","timestamp":1771382795000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjhf\/article\/27\/8\/1393\/8468084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":31,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,7,2]]},"published-print":{"date-parts":[[2025,8,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ejhf.3714","relation":{},"ISSN":["1388-9842","1879-0844"],"issn-type":[{"value":"1388-9842","type":"print"},{"value":"1879-0844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,8]]},"published":{"date-parts":[[2025,7,2]]},"assertion":[{"value":"2025-01-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}